PepGen PEPG
NASDAQ PEPG
$3.11 -0.07 (-2.20%)
As of: Sep 4, 2026 · 3:59 PM EDT

PepGen (PEPG) Retained Earnings (2021 - 2026)

PepGen (PEPG) posted Retained Earnings of -$378.9 million for Q1 2026, down 3444645.45% sequentially from $11000.0 in Q4 2025, and down 1722172.73% YoY from N/an in Q1 2025.

Analysis

PepGen (PEPG) Retained Earnings (2021 - 2026) Analysis & Trends

PepGen has reported Retained Earnings for 6 years, with the latest figure at -$378.9 million in Q1 2026.

  • Quarterly Retained Earnings fell 1722172.73% year-over-year to -$378.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$378.9 million (down 1722172.73% YoY) and the FY2025 annual result came in at $11000.0, down 52.17% from the prior year.
  • Retained Earnings fell to -$378.9 million in Q1 2026 per PEPG's latest filing, from $11000.0 in the prior quarter.
  • Over five years, Retained Earnings peaked at $23000.0 in Q4 2024 and troughed at -$378.9 million in Q1 2026.
  • A 5-year average of -$124.7 million and a median of -$87.9 million in 2022 frame the typical range for Retained Earnings.
  • The sharpest annual moves came in 2024 and 2026: Retained Earnings jumped 100.01% in 2024, then plunged 1722172.73% in 2026.
  • Over 5 years, Retained Earnings stood at -$81000.0 in 2022, then plunged by 223951.85% to -$181.5 million in 2023, then soared by 100.01% to $23000.0 in 2024, then plunged by 52.17% to $11000.0 in 2025, then plunged by 3444645.45% to -$378.9 million in 2026.
  • According to Business Quant data, Retained Earnings over the past three periods registered -$378.9 million, $11000.0, and -$342.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 15.69 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 37.62 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 558.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.10 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -4.00 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 13.05 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -6.33 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 4.38 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.57 Bn
10 PepGen 217.99 Mn 217.99 Mn - -396.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -396.70 Mn
Mar 31, 2026 -378.90 Mn
Dec 31, 2025 -361.12 Mn
Sep 30, 2025 -342.80 Mn
Jun 30, 2025 -324.80 Mn
Mar 31, 2025 -301.70 Mn
Dec 31, 2024 -271.46 Mn
Sep 30, 2024 -249.22 Mn
Jun 30, 2024 -227.84 Mn
Mar 31, 2024 -199.50 Mn
Dec 31, 2023 -181.48 Mn
Sep 30, 2023 -162.00 Mn
Jun 30, 2023 -138.70 Mn
Mar 31, 2023 -119.20 Mn
Dec 31, 2022 -102.86 Mn
Sep 30, 2022 -87.92 Mn
Jun 30, 2022 -69.31 Mn
Mar 31, 2022 -52.00 Mn
Dec 31, 2021 -33.75 Mn